trending Market Intelligence /marketintelligence/en/news-insights/trending/7SQmencI_BGVDqMiLtJ6Vw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Qiagen sticking to stand-alone business plan after completing strategic review

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Qiagen sticking to stand-alone business plan after completing strategic review

Qiagen NV's board has determined, after completing a strategic review, that the company's current stand-alone business plan "represents the best opportunity to drive future value creation."

The supervisory and management board of Netherlands-based Qiagen, which provides solutions for molecular testing for the diagnosis of diseases and the development of treatments, started discussions with interested parties to explore strategic alternatives to maximize shareholder value.

This process was announced in mid-November after Qiagen received several conditional, non-binding indications of interest for a full acquisition. Bloomberg News had reported earlier that Thermo Fisher Scientific Inc. reached out to Qiagen with a potential deal.

Qiagen's board decided that the alternatives to the stand-alone prospects were not compelling and has terminated all discussions so that the company's management can focus on executing the stand-alone plan.